Siemens Healthineers continues to demonstrate robust performance, driven by strong Imaging and Precision Therapy segments, excluding Chinese market recovery. The company reported a 3Q26 book-to-bill ratio of 1.3x and a margin of 19.1%, leading to an increased EPS guidance of €2.45. Despite conservative growth estimates of 3-5% outside China, the stock offers over 15% annualized upside supported by secular healthcare trends and a resilient installed base. The company remains a high-conviction buy with a €48 per share price target.
Brookfield Corporation reported record growth in fee-bearing capital and assets under management in Q2, driving a 15% year-over-year rise in distributable earnings per share. The company plans to enhance share accessibility and liquidity through corp...
In one week, American spot Bitcoin ETFs attracted $1.92 billion in inflows, pushing their total assets under management close to $100 billion. BlackRock's IBIT ETF led Friday's inflows with $239 million, reflecting strong institutional interest. Ethe...
Ameresco has received $1.2 billion in new data-center power infrastructure awards in Q2 2026, increasing its awarded backlog to $4.42 billion, with $1.5 billion tied to data center projects. This backlog significantly exceeds its $2 billion annual re...
Metals One PLC has finalized a phased mine plan for the Barbrook gold project in South Africa, aiming to produce its first gold concentrate within six months using existing processing infrastructure. The company holds a 30% stake in Lions Bay Resourc...
XRP saw a strong rally of over 46% this week, reaching a seven-month high of $1.70 before sharply dropping 14% to $1.46 in the last 24 hours. This pullback triggered more than $250 million in long position liquidations, the highest among large-cap as...
